Pancreatic Cancer Research

ResearcherSoochow UniversityActive in the last 2 years

Xuemin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7387-0662; OpenAlex author ID A5101957486. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 3 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. SUZ12 promotes pancreatic ductal adenocarcinoma progression and chemoresistance by epigenetically silencing NCOA4-induced ferroptosis. Last author DOI 10.3724/abbs.2025215↗
  2. NDUFA4 promotes cell proliferation by enhancing oxidative phosphorylation in pancreatic adenocarcinoma. Co-author DOI 10.1007/s10863-022-09949-0↗
  3. circZMYM2 Competed Endogenously with miR-335-5p to Regulate JMJD2C in Pancreatic Cancer. Co-author DOI 10.1159/000495868↗
  4. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer. First author DOI 10.1186/s12935-018-0643-7↗
  5. MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS. Co-author DOI 10.5114/aoms.2018.72564↗
  6. LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer. Co-author DOI 10.18632/oncotarget.16462↗
  7. Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2. Co-author DOI 10.18632/oncotarget.13490↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huihua Cai · 6 shared papers, 2016–2022 · strength 0.54
  2. Yong An · 5 shared papers, 2016–2018 · strength 0.38
  3. Xiaowu Xu · 1 shared paper, 2026 · strength 0.27
  4. Borui Li · 1 shared paper, 2026 · strength 0.27
  5. Zheng Li · 1 shared paper, 2026 · strength 0.27
  6. Lei Yin · 1 shared paper, 2026 · strength 0.27
  7. Xinquan Wu · 2 shared papers, 2018–2022 · strength 0.24
  8. Di Wu · 2 shared papers, 2017–2022 · strength 0.22
  9. Yue Zhang · 1 shared paper, 2022 · strength 0.16
  10. Yong Yang · 2 shared papers, 2017–2018 · strength 0.16
  11. Yong Jiang · 2 shared papers, 2017–2018 · strength 0.15
  12. Xiaozhou He · 2 shared papers, 2016–2017 · strength 0.12
  13. Xiaozhou He · 1 shared paper, 2018 · strength 0.09
  14. Baoqiang Wu · 1 shared paper, 2018 · strength 0.08
  15. B Y Luo · 1 shared paper, 2017 · strength 0.06
  16. Jie J. Yao · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.